Access-to-results debate
Do now
Argue a CER position on whether patients should receive raw genetic testing results directly.
- Hand in
- One CER on direct patient access to raw genetic results plus a reflection naming one counterargument.
- Where
- Turn this in at the drop folder with your district Microsoft sign-in, or hand it to Mr. Mendoza in class. Both count as submitted. Doing the activity in myPLTW does not.
You get two school days for every day you were absent, so this deadline moves with you.
If a genetic test comes back with a , should the patient see that raw result directly, or only after a clinician explains it?
Argue a CER position on whether patients should receive raw genetic testing results directly.
- • You'll be able to argue a position on direct access to genetic results.
- • You'll be able to address a counterargument with evidence.
- In one sentence, who do you think should be allowed to see raw genetic test results first, the patient or a clinician?
- Name one way a genetic result could be misread by someone without medical training.
- 1Read the access-to-results case brief in the course shell.
- 2Write two prepared questions about giving patients raw results without a clinician.
- 3Draft a CER with a claim, two pieces of evidence, and your reasoning.
- 4In the debate, note one counterargument and whether it changes your position.
- 5Post your CER and reflection in the course shell.
What did this day actually feel like?
Access-to-results debate
ETHICS DAY Should patients get raw genetic results directly, without a clinician interpreting first? Access against the risk of misreading something frightening.
It is your information. It is also information that is easy to misunderstand in a way that causes real harm. Both things are true.
AT HOME, THE NIGHT BEFORE MON OCT 19 PCR and primers Amplifying a tiny amount of DNA into enough to work with, and how the primers decide which region gets copied.
The primers are the specificity. Design them badly and you amplify the wrong thing confidently.
Turned in: notebook → Lab Notebooks folder
Fiction. There is no such student. The lessons, labs and dates are the real planned course; the student, the classmates and the conversations are invented.
The same day, drawn.
Should patients get raw genetic results directly, without a clinician interpreting first? Access against the risk of misreading something frightening.
Fiction. There is no such student. The lessons, labs and dates are the real planned course; the student, the classmates and the conversations are invented.
🛠 Get unstuck · pick your level
🔑 Today's words · 5
Tap a word in the lesson for a plain meaning and one example. Recycled into next week's Do-Now.
Do the work · 80-minute blockfirst 5 min = hook▸
💡 Big idea: Genetic results can be uncertain and easy to misread, so who controls access to them is an ethical decision that can protect or harm a patient.
- 0-5Hook screenshot; frame the debate question
- 5-20Silent read of access-to-results case brief; draft two questions
- 20-35CER draft: claim, two evidences, reasoning
- 35-65Structured debate: direct access yes vs. clinician-mediated only
- 65-75Written reflection: state one counterargument and whether it shifted your position
- 75-80Post CER and reflection to course shell; preview Tuesday PCR work
- • Hook: Show a real direct-to-consumer genetic result screenshot and ask: what would you do if this arrived in your email tonight?
- • Why it matters: Companies like 23andMe now provide raw data downloads; clinicians did not choose this, but patients expect a response.
- • Today's structure: case brief, CER prep, structured debate, reflection.
- • Exit goal: CER and reflection posted to the course shell before the bell.
- • Raw genetic results may include variants of uncertain significance that are easy to misread without training.
- • Proponents of direct access argue that patients own their biological data and have a right to it immediately.
- • The 2013 FDA order restricting 23andMe health reports shows how regulators weigh access against potential harm.
PCR, restriction enzymes, electrophoresis, microarrays, and the limits of each method. · Access-to-results debate
Day 1 of this lesson. Open this exact section in myPLTW (find it in Clever, Microsoft sign-in), then do the work below.
Do this: Open the access-to-results debate activity in myPLTW for Activity 2.1.2 Copying Our Genes (PCR) in Lesson 2.1 Genetic Testing and Screening and review the CER rubric.
Mark the access debate activity complete after your CER is posted.
MP1 tracker should be complete; this opens the testing-methods unit.
Access-to-results CER and reflection visible in the course discussion board.
The official PLTW activity stays inside myPLTW. If myPLTW will not open, use F1 and E1-E3 on this page to complete today's local evidence decision, then make up the official activity when access returns. Turn this in at the drop folder with your district Microsoft sign-in, or hand it to Mr. Mendoza in class. Both count as submitted. Doing the activity in myPLTW does not.
Check things off as you work, then submit. This tells Mr. Mendoza how you're doing so he can help the class. It does not replace turning in your producible through the submission route shown below.
Use the code Mr. Mendoza gave you, not your name. Saved on this device.
PCR, restriction enzymes, electrophoresis, microarrays, and the limits of each method. · Access-to-results debate
Open the access-to-results debate activity in myPLTW for Activity 2.1.2 Copying Our Genes (PCR) in Lesson 2.1 Genetic Testing and Screening and review the CER rubric.
MP1 tracker should be complete; this opens the testing-methods unit.
This is how Mr. Mendoza sees the class keeping pace with PLTW. Be honest, it only helps if it is accurate.
🎯 Argue a CER position on whether patients should receive raw genetic testing results directly.
- Read the access-to-results case brief in the course shell.
- Write two prepared questions about giving patients raw results without a clinician.
- Draft a CER with a claim, two pieces of evidence, and your reasoning.
- In the debate, note one counterargument and whether it changes your position.
- Post your CER and reflection in the course shell.
CER: One CER on direct patient access to raw genetic results plus a reflection naming one counterargument.
Turn this in at the drop folder with your district Microsoft sign-in, or hand it to Mr. Mendoza in class. Both count as submitted. Doing the activity in myPLTW does not. Use the checklist just below and upload by 11:29 PM for full credit. Absent with an excused absence? You get two school days for every day you were absent, so this deadline moves with you.
| Task | Who |
|---|---|
| Read the access-to-results case brief in the course shell. | _______ |
| Write two prepared questions about giving patients raw results without a clinician. | _______ |
| Draft a CER with a claim, two pieces of evidence, and your reasoning. | _______ |
| In the debate, note one counterargument and whether it changes your position. | _______ |
| Post your CER and reflection in the course shell. | _______ |
Working solo? Put your own name in "Who" for every row.
- You'll be able to argue a position on direct access to genetic results.
- You'll be able to address a counterargument with evidence.
- 1Do thisArgue a CER position on whether patients should receive raw genetic testing results directly.
- 2Use this resource
- 3Submit thisCER: One CER on direct patient access to raw genetic results plus a reflection naming one counterargument.
- 4Submit it here
- 1Open the drop folder.
- 2Sign in with your district Microsoft account, not a personal one.
- 3Upload the file, named Lastname_Firstname__Assignment Title.
- 4Your own upload panel says Uploaded with a green check: that is your receipt.
Turn this in at the drop folder with your district Microsoft sign-in, or hand it to Mr. Mendoza in class. Both count as submitted. Doing the activity in myPLTW does not. Genetics of Disease (Medical Interventions) › PCR, restriction enzymes, electrophoresis, microarrays, and the limits of each method. › CEROpen the drop folder
Learn it · deck, reading, and vocabulary▸
The deck carries the prior idea forward, lets you inspect an analogy, maps the rule to biology, and ends with the same evidence decision and exit ticket used on this page.
Generated from this lesson's canonical data with a red-team citation check.
A holds one non-working but usually never gets sick, so an honest counseling memo must report reproductive odds without letting 'positive' be misread as a diagnosis.
Genetic results can be uncertain and easy to misread, so who controls access to them is an ethical decision that can protect or harm a patient.
A smoke alarm detects signs of fire but can also react to burnt toast.
- What does the alarm detect?
- What creates a false alarm?
- What evidence is needed before declaring a fire?
A screening signal changes what to investigate next; it does not automatically prove the cause.
Biomedical tests have measured performance and biological sampling limits that a household alarm does not capture.
- • Alarm signal maps to a test result.
- • Burnt toast maps to a .
- • Inspection maps to confirmation or the next test.
Driving question: If a genetic test comes back with a , should the patient see that raw result directly, or only after a clinician explains it?
What you already know: A holds one non-working but usually never gets sick, so an honest counseling memo must report reproductive odds without letting 'positive' be misread as a diagnosis.
New idea: Genetic results can be uncertain and easy to misread, so who controls access to them is an ethical decision that can protect or harm a patient.
Visual or model: F1. F1. A lesson illustration or teaching diagram for Access-to-results debate. Use it with E1-E3; it is a model or context image, not experimental or patient data. What to notice: Trace the labeled testing, treatment, or biological process and identify where evidence limits the decision.
- Observe or measure the relevant feature in Access-to-results debate.
- Organize the observation with a stable evidence ID.
- Apply this rule: A screening signal changes what to investigate next; it does not automatically prove the cause.
- Choose the option the evidence supports and state the limit of the conclusion.
Real biomedical example: If a genetic test comes back with a , should the patient see that raw result directly, or only after a clinician explains it?
What the evidence supports: E1-E3 and F1 support the daily take-home when the response meets the stated success criteria.
What it cannot prove: The package does not support claims beyond this lesson's or any real patient diagnosis.
- • : A short single strand of DNA that binds to a target sequence and gives DNA polymerase a starting point to build a new strand, as in PCR.
- • : A that recognizes a specific and cuts the strand there, a key tool for cutting and studying genes.
- • : A lab technique that uses an electric current to pull DNA or fragments through a gel, separating them by size.
- • : A chip holding thousands of tiny DNA spots that lets scientists measure the activity of many genes at once by detecting which spots light up.
- • : The pairing of two single DNA or RNA strands with matching base sequences into a double strand, used in tests to detect a specific gene.
- • marker: A measurable feature, molecule, or gene used to identify a cell, organism, or condition, like a flag that signals something specific.
Use it now: Choose one decision option. Cite E1 and E3, then explain how the rule connects the evidence to your choice.
Go further, optional: The source links below are optional enrichment. Every fact required for today's local evidence decision appears in this lesson package.
Raw genetic results may include variants of uncertain significance that are easy to misread without training.
Limit: E1 supplies context or an observation; it does not by itself establish the explanation.
Genetic results can be uncertain and easy to misread, so who controls access to them is an ethical decision that can protect or harm a patient.
Limit: E2 is a teaching statement or comparison and must be checked against the task evidence.
You'll be able to argue a position on direct access to genetic results.
Limit: E3 supports only the result or product criterion named here; it cannot justify a broader clinical or causal claim.
PLTW-GEND-2026-10-16 · Simulated classroom evidence scenario
Your role: medical interventions team member
Decision: Your team must decide what the evidence from Access-to-results debate supports before submitting the claim-evidence-reasoning response named on the lesson page.
- • Choose the strongest supported explanation.
- • Choose the next evidence to collect.
- • Hold the decision because the evidence is insufficient.
Response: State one choice, cite at least two evidence IDs, explain the rule that connects them, and add one limitation. Submit it as the claim-evidence-reasoning response.
Claim ceiling: The supplied lesson evidence can support an observation, pattern, classroom mechanism, or next-step decision about Access-to-results debate. It cannot by itself prove causation, establish a real clinical diagnosis, or justify action outside this classroom task.
Reason for review: Your team must decide what the evidence from Access-to-results debate supports before submitting the claim-evidence-reasoning response named on the lesson page.
Context: Genetic information is powerful and easy to misread, so who controls access to it is a medical and ethical decision, not just a technical one.
- • T1: Read the access-to-results case brief in the course shell.
- • T2: Write two prepared questions about giving patients raw results without a clinician.
- • T3: Draft a CER with a claim, two pieces of evidence, and your reasoning.
- • T4: In the debate, note one counterargument and whether it changes your position.
- • T5: Post your CER and reflection in the course shell.
- • E1: Raw genetic results may include variants of uncertain significance that are easy to misread without training.
- • E2: Genetic results can be uncertain and easy to misread, so who controls access to them is an ethical decision that can protect or harm a patient.
- • E3: You'll be able to argue a position on direct access to genetic results.
Measurements: Use only the measurements, units, graph, or counts supplied in today's task. No additional patient measurement is implied.
Figure finding: Teaching diagram for Access-to-results debate. Trace the labeled testing, treatment, or biological process and identify where evidence limits the decision. This is a teaching model, not patient or experimental data.
Uncertainty: This is a composite classroom scenario. Missing history, measurements, or confirmation tests remain unknown and limit the conclusion.
Mean = sum of values / number of values. Median = middle ordered value. Range = maximum - minimum.
For 2, 4, 4, and 10: mean = 20 / 4 = 5, median = 4, and range = 10 - 2 = 8.
Mean, median, and range keep the measurement unit. Order the values before finding the median.
Calculate the requested summary for today's supplied values, then write what it reveals and what it hides.
Students often think Students often think a genetic test gives a clear yes-or-no answer, like a pregnancy test, so raw results are always safe to hand straight to the patient.. The trap: Many results are variants of uncertain significance, meaning even experts do not yet know if they cause disease. Treating an uncertain variant as a diagnosis is the trap, because it can trigger fear or medical decisions the evidence does not support.
Claim: States should be allowed to store leftover newborn screening blood spots for future research, but only if parents are clearly told and can opt out.\n\nEvidence 1: Every newborn is screened for genetic disorders using a heel-stick blood spot, and the leftover cards contain a child's DNA, which can reveal far more than the original tests checked for.\n\nEvidence 2: In Texas in 2009, a lawsuit revealed that stored newborn blood spots had been used for research without parents' knowledge, and the state was ordered to destroy millions of samples, showing that hidden storage breaks public trust.\n\nReasoning: Stored blood spots are genuinely useful for studying diseases and improving future screening, so destroying them all wastes a resource that could help other children. But the DNA belongs to the child and the family, not the state, and using it in secret treats people as sources of data rather than as patients. Requiring clear notice and an opt-out respects the family's ownership of the sample while still allowing research that benefits the public.\n\nReflection: One counterargument is that an opt-out will shrink the sample pool and slow research, since many families will decline once they are asked. I took that seriously, but I kept my claim, because trust is what keeps the whole screening program running. If families fear their child's DNA is used behind their backs, they may resist screening itself, and the public-health cost of that distrust is higher than the cost of a smaller research pool.
This model shows the level of evidence and organization needed to complete: Worked CER on a parallel case: a claim about whether the state should keep leftover newborn screening blood spots for later research, two pieces of evidence, reasoning, and a reflection naming one counterargument. Models the CER format and depth for the access-to-results debate without answering today's own prompt about raw genetic results.
- Write one defensible claim.
- Choose specific evidence that supports the claim.
- Explain the scientific rule that connects the evidence to the claim.
Keep the structure. Replace the question, facts, measurements, and evidence. Then recheck units, vocabulary, and whether the conclusion goes beyond the evidence.
Also due today: Post your CER and reflection to the PLTW course shell.
- CER:
- Claim, Evidence, Reasoning: make a claim, back it with evidence, explain your reasoning.
- SOP:
- Standard Operating Procedure, the exact steps to follow (especially in a lab).
- Tracker:
- Your PLTW progress log where you record completed evidence.
- myPLTW:
- The PLTW course site where you do the online activities. Find it in Clever with your Microsoft sign-in, right next to Schoology.
Tap the speaker to hear a term. Add two of these to your notebook glossary with a definition and an example in your own words.
Pick just 2 or 3 words from today and make them yours: write what each one means in your own words, name the context clue or evidence that helped, then give one example from what you actually did in Access-to-results debate. Try your own words first; the glossary is there if you get stuck. This is voluntary and counts as extra credit, so keep it short.
Saved on this device. Show Mr. Mendoza or add these to your notebook glossary to claim the extra credit.
Classroom documents for this lesson are posted in Schoology. Open Clever, then Schoology, and find each one by the name shown on its card.
Open this when the class reaches this activity and use it to complete the required lesson artifact.
Placement rationale
Matched PCR, , microarrays by path:Medical-Interventions/Unit-2_How-to-Screen-Your-Genes/2.1_Genetic-Testing-and-Screening; keywords:pcr, gel electrophoresis. Score 142. Visibility: student-schoology (student-facing resource; link through Schoology rather than local path).
Use this if you were absent, got stuck, or need another pass before you submit the lesson artifact.
Placement rationale
Matched PCR, , microarrays by path:Medical-Interventions/Unit-2_How-to-Screen-Your-Genes/00_Unit-Overview; keywords:pcr, gel electrophoresis. Score 138. Visibility: student-schoology (student-facing resource; link through Schoology rather than local path).
Use this after the required lesson work when you are ready for a harder application or a deeper connection.
Placement rationale
Matched PCR, , microarrays by path:Medical-Interventions/Unit-2_How-to-Screen-Your-Genes/2.1_Genetic-Testing-and-Screening; keywords:gel electrophoresis. Score 134. Visibility: student-schoology (student-facing resource; link through Schoology rather than local path).
How to get there: open Clever and sign in with your Microsoft (district) account. Both myPLTW and Schoology are in Clever. Do the activity in myPLTW. Turn the work in on this site or hand it to Mr. Mendoza, because that is the step that counts as submitted. Schoology only shows your report-card grade later.
Check yourself · commit, then reveal▸
Claim ceiling for this check: The supplied lesson evidence can support an observation, pattern, classroom mechanism, or next-step decision about Access-to-results debate. It cannot by itself prove causation, establish a real clinical diagnosis, or justify action outside this classroom task.
A patient's report shows a variant labeled variant of uncertain significance. Why is this result hard to hand directly to the patient without a clinician?
Write an answer and pick a confidence to unlock the key.
Fast retrieval with instant answers, not the commit-then-reveal check above. Try each from memory first: write what you remember about the earlier units, then check yourself here.
Go further and get help▸
What today's skills lead to. These are real health-science careers this course builds toward. Tap one to see, on the US Department of Labor's O*NET site, what the job actually involves, what it pays, and how fast it is growing.
Use to test how conserved IRF6 is across humans, mice, and zebrafish.
Goes with: BLAST: is IRF6 conserved across species?
Search ClinVar for which IRF6 changes are known to cause disease.
Goes with: ClinVar: which IRF6 changes cause disease?
Missed the live debate? Watch the linked overview and post a written CER on direct access to results plus your two questions and a reflection in the PLTW course shell.
Then submit your CER. Turn this in at the drop folder with your district Microsoft sign-in, or hand it to Mr. Mendoza in class. Both count as submitted. Doing the activity in myPLTW does not.
Class still runs. Complete the online activity above (it's self-guided). Need the concept taught without a teacher? Use this authoritative explainer:
Genetic Science Learning Center: Gel Electrophoresis- CompleteEvery required part of the artifact is present, nothing left blank.
- AccurateThe science and the data are correct and match the evidence.
- Scientific reasoningYou explain your claim with evidence and reasoning (CER), not just an answer.
- Professional communicationClear, organized, labeled, and written the way a clinician or scientist would.
- SubmittedTurned in the right way, on the class site or handed to Mr. Mendoza in class, and confirmed. Not in Schoology: that is where the report-card grade appears later.